STAT

Opinion: Abundant research shows gender disparities in medicine, but too few know about it. #NeedHerScience

Editors of medical journals can help disseminate research on gender disparities in medicine with a relatively simple deed: making such research freely available to everyone. #NeedHerScience

Medicine has an abundance of highly trained and qualified women. So why are there so few of them at the highest levels, including full professors, chairs, and deans?

For many years, the belief was that when there were enough women in medicine, critical mass alone would correct such gender disparities. Yet this theory has not panned out and it is now clear that despite the fact  there are many qualified women for any given leadership position, they are not promoted equitably.

Dr. Keith Lillemoe summed it up nicely during his presidential address to the American Surgical Association when he said, “The number of outstanding, qualified female candidates is more than adequate to fill every open surgical leadership position in America today. The problem is not the pipeline — it is the process.”

Slow progress in gender equity isn’t limited to medicine, of course. It is universal, which is why that her

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks